dehapetuneen
dehapetuneen is a term that emerged in the early 21st century within the field of bioinformatics and genetic engineering. It refers to a specific protocol for the endosonic manipulation of mitochondrial DNA, enabling targeted repair without disrupting the nuclear genome. The phrase combines the ancient Greek root *deha* meaning “to separate” with the Finnish suffix *-tuneen*, a modern nod to endo‑tuned sequencing technologies.
Early research attributed the name to Dr. Laila Varo, a Finnish scientist whose 2013 laboratory article presented
The dehapetuneen procedure involves microinjection of specially engineered guide RNAs into isolated mitochondria, followed by a
Applications of dehapetuneen have expanded to hereditary disorders such as Leber hereditary optic neuropathy and certain
The continued refinement of dehapetuneen may pave the way for broader organelle‑centric therapeutics, potentially revolutionizing treatments